脉冲射频神经调节用于中风后的肩部疼痛在患有出血性中风的患者
Doyoung Na1, Mu Seung Park1, Hyuk Jai Choi1
1Department of Neurosurgery, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, Chucheon, Korea.
Journal of Korean Neurosurgical Society
|February 15, 2024
概括
头骨上神经的脉冲射频 (PRF) 神经调节为中风后肩部疼痛 (PSSP) 提供了长期的解决方案. 这种治疗有效减少疼痛,改善肩膀功能和生活质量.
科学领域:
- 神经学 神经学
- 疼痛管理 疼痛管理
- 康复医学 康复医学 康复医学
背景情况:
- 脑卒中后肩部疼痛 (PSSP) 显著影响患者的康复和生活质量 (QoL).
- 现有的PSSP治疗方法往往缺乏长期的疗效.
- 头骨上神经神经调节正在作为一种潜在的治疗途径进行探索.
研究的目的:
- 为了评估脉冲射频 (PRF) 神经调节在PSSP上头骨上神经的临床疗效.
- 评估PRF治疗对疼痛和肩部功能的长期影响.
- 为了确定PRF是否为PSSP提供了优越的治疗选择.
主要方法:
- 一个回顾13名PSSP患者的病例系列,他们接受了PRF神经调节的头骨上神经.
- 主要结局:用于疼痛的视觉模拟尺度 (VAS).
- 二次结果:肩部运动范围 (ROM),残疾评估量表 (DAS),修改的阿什沃思量表,修改的兰金量表 (mRS) 和EuroQol-5维度-3L (EQ-5D-3L) 问卷.
主要成果:
- 从手术前的7.07到手术后的2.38的VAS平均得分显著降低.
- 在肩膀ROM (绑架和曲),DAS,mRS和EQ-5D-3L得分中观察到明显的改善.
- 所有患者都被跟踪了至少12个月,没有报告的并发症.
结论:
- 上神经的PRF神经调节是PSSP的有效治疗方法.
- 这种模式在缓解疼痛和改善QOL方面提供了长期的效果.
- PRF神经调节是一种有前途的治疗选择,用于管理PSSP.
更多相关视频
04:49Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes
Published on: September 6, 2024
743
05:28Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies
Published on: October 11, 2024
576
相关概念视频
01:26Flail Chest-II
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
01:25Pericarditis IV: Nursing Management
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
01:20Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.